Citations 1
Protein activation mapping and exploratory predictive markers for pCR in triple-negative breast cancer patients treated with neratinib in the I-SPY 2 TRIAL.
Wulfkuhle, Julia , Deng, Jianghong , Hirst, Gillian L. , Liu, Minetta C. , Park, John W., Berry, Donald A. , Veer, Laura van’t, Petricoin, Emanuel F. , Investigators, I-SPY 2 TRIAL, Hirst, Gillian L , Yau, Christina , Wolf, Denise M. , Gallagher, Rosa I. , Swigart, Lamorna Brown , Esserman, Laura J. , Investigators, I-SPY 2 TRIAL
Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 1085-1085
